Bronchodilator Dosing
Bronchodilator Dosing is a clinical methodology that specifies the precise administration regimen of bronchodilatory agents, differentiating it from other therapeutic interventions by its focus on optimizing drug amount, frequency, and delivery route to achieve maximal airway dilation with minimal adverse effects in respiratory conditions.
306
Publications
14.1K
Citations
1.2K
Authors
442
Institutions
Publications per year
2017–2026
9
Parents
306
Michael R. Littner, Jonathan Ilowite, Donald P. Tashkin et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 220 citations
1–5 of 306
1.2K
10
h-index
6
h-index
6
h-index
University of Campania "Luigi Vanvitelli", Italy
6 publications · 386 citations
6
h-index
6
h-index
1–5 of 1.2K
442
Novartis (United Kingdom)
Frimley, United Kingdom
8 h-index
22 publications
2.1K citations

McMaster University
Hamilton, Canada
8 h-index
22 publications
896 citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
8 h-index
18 publications
557 citations

National Jewish Health
Denver, United States
7 h-index
8 publications
713 citations

Ninewells Hospital
Dundee, United Kingdom
7 h-index
30 publications
1.7K citations
Pulmonary Associates
Phoenix, United States
7 h-index
12 publications
532 citations

University of Colorado Denver
Denver, United States
7 h-index
8 publications
713 citations
Novartis (Switzerland)
Basel, Switzerland
7 h-index
16 publications
565 citations
1–8 of 442
32 publications · 1.7K citations
24
h-index
32 publications · 1.1K citations
21
h-index
Repository · 36 publications · 793 citations
17
h-index
17 publications · 731 citations
15
h-index
11 publications · 856 citations
11
h-index
1–5